Of the five patients with relapse after transplantation, three patients were diagnosed as MDS EB-2 before transplantation, and two patients were diagnosed as T lymphoblastic lymphoma (CR1) and MLL-AF9 AML (CR1). The gene discussed is KMT2A; the disease is T-lymphoblastic lymphoma.